- Home
- DRH vs BHVN Comparison
DRH vs BHVN Comparison
Compare DRH & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRH
- BHVN
- Stock Information
- Founded
- DRH 2004
- BHVN 2013
- Country
- DRH United States
- BHVN United States
- Employees
- DRH N/A
- BHVN N/A
- Industry
- DRH Real Estate Investment Trusts
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- DRH Real Estate
- BHVN Health Care
- Exchange
- DRH Nasdaq
- BHVN Nasdaq
- Market Cap
- DRH 1.7B
- BHVN 1.5B
- IPO Year
- DRH 2005
- BHVN 2017
- Fundamental
- Price
- DRH $8.19
- BHVN $13.49
- Analyst Decision
- DRH Hold
- BHVN Strong Buy
- Analyst Count
- DRH 6
- BHVN 15
- Target Price
- DRH $8.63
- BHVN $53.86
- AVG Volume (30 Days)
- DRH 2.5M
- BHVN 2.1M
- Earning Date
- DRH 11-06-2025
- BHVN 11-11-2025
- Dividend Yield
- DRH 3.90%
- BHVN N/A
- EPS Growth
- DRH N/A
- BHVN N/A
- EPS
- DRH 0.28
- BHVN N/A
- Revenue
- DRH $1,124,753,000.00
- BHVN N/A
- Revenue This Year
- DRH N/A
- BHVN N/A
- Revenue Next Year
- DRH $2.31
- BHVN $2,195.07
- P/E Ratio
- DRH $29.45
- BHVN N/A
- Revenue Growth
- DRH 1.72
- BHVN N/A
- 52 Week Low
- DRH $6.19
- BHVN $12.79
- 52 Week High
- DRH $10.00
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- DRH 46.97
- BHVN 37.97
- Support Level
- DRH $8.29
- BHVN $13.63
- Resistance Level
- DRH $8.72
- BHVN $14.23
- Average True Range (ATR)
- DRH 0.16
- BHVN 0.82
- MACD
- DRH -0.05
- BHVN -0.25
- Stochastic Oscillator
- DRH 11.43
- BHVN 1.95
About DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.